nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonazepam—CYP2E1—Mitoxantrone—lymphatic system cancer	0.155	0.359	CbGbCtD
Clonazepam—CYP3A4—Cytarabine—lymphatic system cancer	0.0683	0.158	CbGbCtD
Clonazepam—CYP3A4—Teniposide—lymphatic system cancer	0.0673	0.155	CbGbCtD
Clonazepam—ALB—Methotrexate—lymphatic system cancer	0.0625	0.145	CbGbCtD
Clonazepam—CYP3A4—Mitoxantrone—lymphatic system cancer	0.047	0.109	CbGbCtD
Clonazepam—CYP3A4—Vincristine—lymphatic system cancer	0.0324	0.0748	CbGbCtD
Clonazepam—Cystitis noninfective—Methotrexate—lymphatic system cancer	0.00104	0.00184	CcSEcCtD
Clonazepam—Malaise—Bleomycin—lymphatic system cancer	0.00104	0.00183	CcSEcCtD
Clonazepam—Pruritus—Teniposide—lymphatic system cancer	0.00103	0.00182	CcSEcCtD
Clonazepam—Leukopenia—Bleomycin—lymphatic system cancer	0.00103	0.00182	CcSEcCtD
Clonazepam—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00103	0.00182	CcSEcCtD
Clonazepam—Cystitis—Methotrexate—lymphatic system cancer	0.00103	0.00182	CcSEcCtD
Clonazepam—Cardiac disorder—Vincristine—lymphatic system cancer	0.00102	0.00181	CcSEcCtD
Clonazepam—Alopecia—Carmustine—lymphatic system cancer	0.00102	0.0018	CcSEcCtD
Clonazepam—Body temperature increased—Fludarabine—lymphatic system cancer	0.00101	0.00179	CcSEcCtD
Clonazepam—Mental disorder—Carmustine—lymphatic system cancer	0.00101	0.00179	CcSEcCtD
Clonazepam—Vaginal infection—Methotrexate—lymphatic system cancer	0.00101	0.00178	CcSEcCtD
Clonazepam—Malnutrition—Carmustine—lymphatic system cancer	0.00101	0.00177	CcSEcCtD
Clonazepam—Cough—Bleomycin—lymphatic system cancer	0.00101	0.00177	CcSEcCtD
Clonazepam—Diarrhoea—Teniposide—lymphatic system cancer	0.000999	0.00176	CcSEcCtD
Clonazepam—Chest pain—Bleomycin—lymphatic system cancer	0.000982	0.00173	CcSEcCtD
Clonazepam—Myalgia—Bleomycin—lymphatic system cancer	0.000982	0.00173	CcSEcCtD
Clonazepam—Alopecia—Vincristine—lymphatic system cancer	0.000976	0.00172	CcSEcCtD
Clonazepam—Coma—Methotrexate—lymphatic system cancer	0.000975	0.00172	CcSEcCtD
Clonazepam—Back pain—Carmustine—lymphatic system cancer	0.000974	0.00172	CcSEcCtD
Clonazepam—Discomfort—Bleomycin—lymphatic system cancer	0.00097	0.00171	CcSEcCtD
Clonazepam—Mental disorder—Vincristine—lymphatic system cancer	0.000967	0.0017	CcSEcCtD
Clonazepam—Chills—Mitoxantrone—lymphatic system cancer	0.000965	0.0017	CcSEcCtD
Clonazepam—Bladder pain—Methotrexate—lymphatic system cancer	0.000964	0.0017	CcSEcCtD
Clonazepam—Urine output increased—Methotrexate—lymphatic system cancer	0.000964	0.0017	CcSEcCtD
Clonazepam—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000954	0.00168	CcSEcCtD
Clonazepam—Alopecia—Mitoxantrone—lymphatic system cancer	0.00095	0.00167	CcSEcCtD
Clonazepam—Confusional state—Bleomycin—lymphatic system cancer	0.000949	0.00167	CcSEcCtD
Clonazepam—Vision blurred—Carmustine—lymphatic system cancer	0.000949	0.00167	CcSEcCtD
Clonazepam—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000946	0.00167	CcSEcCtD
Clonazepam—Tremor—Carmustine—lymphatic system cancer	0.000943	0.00166	CcSEcCtD
Clonazepam—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000941	0.00166	CcSEcCtD
Clonazepam—Oedema—Bleomycin—lymphatic system cancer	0.000941	0.00166	CcSEcCtD
Clonazepam—Infection—Bleomycin—lymphatic system cancer	0.000935	0.00165	CcSEcCtD
Clonazepam—Anaemia—Carmustine—lymphatic system cancer	0.000931	0.00164	CcSEcCtD
Clonazepam—Back pain—Vincristine—lymphatic system cancer	0.00093	0.00164	CcSEcCtD
Clonazepam—Vomiting—Teniposide—lymphatic system cancer	0.000929	0.00164	CcSEcCtD
Clonazepam—Agitation—Carmustine—lymphatic system cancer	0.000925	0.00163	CcSEcCtD
Clonazepam—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000922	0.00162	CcSEcCtD
Clonazepam—Asthenia—Fludarabine—lymphatic system cancer	0.000921	0.00162	CcSEcCtD
Clonazepam—Rash—Teniposide—lymphatic system cancer	0.000921	0.00162	CcSEcCtD
Clonazepam—Dermatitis—Teniposide—lymphatic system cancer	0.00092	0.00162	CcSEcCtD
Clonazepam—Headache—Teniposide—lymphatic system cancer	0.000915	0.00161	CcSEcCtD
Clonazepam—Pruritus—Fludarabine—lymphatic system cancer	0.000908	0.0016	CcSEcCtD
Clonazepam—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000908	0.0016	CcSEcCtD
Clonazepam—Back pain—Mitoxantrone—lymphatic system cancer	0.000905	0.0016	CcSEcCtD
Clonazepam—Leukopenia—Carmustine—lymphatic system cancer	0.000901	0.00159	CcSEcCtD
Clonazepam—Anorexia—Bleomycin—lymphatic system cancer	0.000897	0.00158	CcSEcCtD
Clonazepam—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000894	0.00158	CcSEcCtD
Clonazepam—Anaemia—Vincristine—lymphatic system cancer	0.000888	0.00157	CcSEcCtD
Clonazepam—Agitation—Vincristine—lymphatic system cancer	0.000883	0.00156	CcSEcCtD
Clonazepam—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000882	0.00155	CcSEcCtD
Clonazepam—Polyuria—Methotrexate—lymphatic system cancer	0.000882	0.00155	CcSEcCtD
Clonazepam—Hypotension—Bleomycin—lymphatic system cancer	0.00088	0.00155	CcSEcCtD
Clonazepam—Diarrhoea—Fludarabine—lymphatic system cancer	0.000878	0.00155	CcSEcCtD
Clonazepam—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000868	0.00153	CcSEcCtD
Clonazepam—Nausea—Teniposide—lymphatic system cancer	0.000868	0.00153	CcSEcCtD
Clonazepam—Anaemia—Mitoxantrone—lymphatic system cancer	0.000865	0.00152	CcSEcCtD
Clonazepam—Vertigo—Vincristine—lymphatic system cancer	0.000863	0.00152	CcSEcCtD
Clonazepam—Leukopenia—Vincristine—lymphatic system cancer	0.00086	0.00152	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000858	0.00151	CcSEcCtD
Clonazepam—Chest pain—Carmustine—lymphatic system cancer	0.000857	0.00151	CcSEcCtD
Clonazepam—Myalgia—Carmustine—lymphatic system cancer	0.000857	0.00151	CcSEcCtD
Clonazepam—Anxiety—Carmustine—lymphatic system cancer	0.000854	0.00151	CcSEcCtD
Clonazepam—Malaise—Mitoxantrone—lymphatic system cancer	0.000844	0.00149	CcSEcCtD
Clonazepam—Dyspnoea—Bleomycin—lymphatic system cancer	0.000839	0.00148	CcSEcCtD
Clonazepam—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000838	0.00148	CcSEcCtD
Clonazepam—Confusional state—Carmustine—lymphatic system cancer	0.000828	0.00146	CcSEcCtD
Clonazepam—Oedema—Carmustine—lymphatic system cancer	0.000822	0.00145	CcSEcCtD
Clonazepam—Decreased appetite—Bleomycin—lymphatic system cancer	0.000818	0.00144	CcSEcCtD
Clonazepam—Myalgia—Vincristine—lymphatic system cancer	0.000818	0.00144	CcSEcCtD
Clonazepam—Visual disturbance—Methotrexate—lymphatic system cancer	0.000817	0.00144	CcSEcCtD
Clonazepam—Cough—Mitoxantrone—lymphatic system cancer	0.000817	0.00144	CcSEcCtD
Clonazepam—Infection—Carmustine—lymphatic system cancer	0.000816	0.00144	CcSEcCtD
Clonazepam—Vomiting—Fludarabine—lymphatic system cancer	0.000816	0.00144	CcSEcCtD
Clonazepam—Rash—Fludarabine—lymphatic system cancer	0.000809	0.00143	CcSEcCtD
Clonazepam—Dermatitis—Fludarabine—lymphatic system cancer	0.000809	0.00143	CcSEcCtD
Clonazepam—Pain—Bleomycin—lymphatic system cancer	0.000805	0.00142	CcSEcCtD
Clonazepam—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000804	0.00142	CcSEcCtD
Clonazepam—Headache—Fludarabine—lymphatic system cancer	0.000804	0.00142	CcSEcCtD
Clonazepam—Tachycardia—Carmustine—lymphatic system cancer	0.000802	0.00141	CcSEcCtD
Clonazepam—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000797	0.0014	CcSEcCtD
Clonazepam—Myalgia—Mitoxantrone—lymphatic system cancer	0.000797	0.0014	CcSEcCtD
Clonazepam—Chest pain—Mitoxantrone—lymphatic system cancer	0.000797	0.0014	CcSEcCtD
Clonazepam—Anxiety—Mitoxantrone—lymphatic system cancer	0.000794	0.0014	CcSEcCtD
Clonazepam—Lethargy—Methotrexate—lymphatic system cancer	0.00079	0.00139	CcSEcCtD
Clonazepam—Discomfort—Mitoxantrone—lymphatic system cancer	0.000787	0.00139	CcSEcCtD
Clonazepam—Oedema—Vincristine—lymphatic system cancer	0.000784	0.00138	CcSEcCtD
Clonazepam—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000784	0.00138	CcSEcCtD
Clonazepam—Anorexia—Carmustine—lymphatic system cancer	0.000783	0.00138	CcSEcCtD
Clonazepam—Infection—Vincristine—lymphatic system cancer	0.000779	0.00137	CcSEcCtD
Clonazepam—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000776	0.00137	CcSEcCtD
Clonazepam—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000774	0.00136	CcSEcCtD
Clonazepam—Confusional state—Mitoxantrone—lymphatic system cancer	0.00077	0.00136	CcSEcCtD
Clonazepam—Nervous system disorder—Vincristine—lymphatic system cancer	0.000769	0.00136	CcSEcCtD
Clonazepam—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000768	0.00135	CcSEcCtD
Clonazepam—Hypotension—Carmustine—lymphatic system cancer	0.000768	0.00135	CcSEcCtD
Clonazepam—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000764	0.00135	CcSEcCtD
Clonazepam—Oedema—Mitoxantrone—lymphatic system cancer	0.000764	0.00135	CcSEcCtD
Clonazepam—Nausea—Fludarabine—lymphatic system cancer	0.000763	0.00134	CcSEcCtD
Clonazepam—Infection—Mitoxantrone—lymphatic system cancer	0.000759	0.00134	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000749	0.00132	CcSEcCtD
Clonazepam—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000748	0.00132	CcSEcCtD
Clonazepam—Urticaria—Bleomycin—lymphatic system cancer	0.000748	0.00132	CcSEcCtD
Clonazepam—Anorexia—Vincristine—lymphatic system cancer	0.000748	0.00132	CcSEcCtD
Clonazepam—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000746	0.00131	CcSEcCtD
Clonazepam—Body temperature increased—Bleomycin—lymphatic system cancer	0.000744	0.00131	CcSEcCtD
Clonazepam—Insomnia—Carmustine—lymphatic system cancer	0.000743	0.00131	CcSEcCtD
Clonazepam—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000742	0.00131	CcSEcCtD
Clonazepam—Irritability—Methotrexate—lymphatic system cancer	0.000739	0.0013	CcSEcCtD
Clonazepam—Mood swings—Methotrexate—lymphatic system cancer	0.000734	0.00129	CcSEcCtD
Clonazepam—Hypotension—Vincristine—lymphatic system cancer	0.000733	0.00129	CcSEcCtD
Clonazepam—Dyspnoea—Carmustine—lymphatic system cancer	0.000733	0.00129	CcSEcCtD
Clonazepam—Somnolence—Carmustine—lymphatic system cancer	0.00073	0.00129	CcSEcCtD
Clonazepam—Anorexia—Mitoxantrone—lymphatic system cancer	0.000728	0.00128	CcSEcCtD
Clonazepam—Ataxia—Methotrexate—lymphatic system cancer	0.000728	0.00128	CcSEcCtD
Clonazepam—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000715	0.00126	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000715	0.00126	CcSEcCtD
Clonazepam—Decreased appetite—Carmustine—lymphatic system cancer	0.000714	0.00126	CcSEcCtD
Clonazepam—Hypotension—Mitoxantrone—lymphatic system cancer	0.000714	0.00126	CcSEcCtD
Clonazepam—Insomnia—Vincristine—lymphatic system cancer	0.000709	0.00125	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000709	0.00125	CcSEcCtD
Clonazepam—Pain—Carmustine—lymphatic system cancer	0.000703	0.00124	CcSEcCtD
Clonazepam—Constipation—Carmustine—lymphatic system cancer	0.000703	0.00124	CcSEcCtD
Clonazepam—Breast disorder—Methotrexate—lymphatic system cancer	0.0007	0.00123	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000696	0.00123	CcSEcCtD
Clonazepam—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000694	0.00122	CcSEcCtD
Clonazepam—Decreased appetite—Vincristine—lymphatic system cancer	0.000682	0.0012	CcSEcCtD
Clonazepam—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000681	0.0012	CcSEcCtD
Clonazepam—Somnolence—Mitoxantrone—lymphatic system cancer	0.000679	0.0012	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000677	0.00119	CcSEcCtD
Clonazepam—Feeling abnormal—Carmustine—lymphatic system cancer	0.000677	0.00119	CcSEcCtD
Clonazepam—Fatigue—Vincristine—lymphatic system cancer	0.000676	0.00119	CcSEcCtD
Clonazepam—Asthenia—Bleomycin—lymphatic system cancer	0.000675	0.00119	CcSEcCtD
Clonazepam—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000672	0.00119	CcSEcCtD
Clonazepam—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000672	0.00118	CcSEcCtD
Clonazepam—Constipation—Vincristine—lymphatic system cancer	0.000671	0.00118	CcSEcCtD
Clonazepam—Pain—Vincristine—lymphatic system cancer	0.000671	0.00118	CcSEcCtD
Clonazepam—Asthma—Methotrexate—lymphatic system cancer	0.000669	0.00118	CcSEcCtD
Clonazepam—Pruritus—Bleomycin—lymphatic system cancer	0.000666	0.00117	CcSEcCtD
Clonazepam—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000664	0.00117	CcSEcCtD
Clonazepam—Eosinophilia—Methotrexate—lymphatic system cancer	0.000663	0.00117	CcSEcCtD
Clonazepam—Fatigue—Mitoxantrone—lymphatic system cancer	0.000659	0.00116	CcSEcCtD
Clonazepam—Pain—Mitoxantrone—lymphatic system cancer	0.000653	0.00115	CcSEcCtD
Clonazepam—Constipation—Mitoxantrone—lymphatic system cancer	0.000653	0.00115	CcSEcCtD
Clonazepam—Abdominal pain—Carmustine—lymphatic system cancer	0.00065	0.00114	CcSEcCtD
Clonazepam—Body temperature increased—Carmustine—lymphatic system cancer	0.00065	0.00114	CcSEcCtD
Clonazepam—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000642	0.00113	CcSEcCtD
Clonazepam—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000641	0.00113	CcSEcCtD
Clonazepam—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000629	0.00111	CcSEcCtD
Clonazepam—Dysuria—Methotrexate—lymphatic system cancer	0.000626	0.0011	CcSEcCtD
Clonazepam—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000625	0.0011	CcSEcCtD
Clonazepam—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000622	0.0011	CcSEcCtD
Clonazepam—Body temperature increased—Vincristine—lymphatic system cancer	0.00062	0.00109	CcSEcCtD
Clonazepam—Abdominal pain—Vincristine—lymphatic system cancer	0.00062	0.00109	CcSEcCtD
Clonazepam—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000616	0.00109	CcSEcCtD
Clonazepam—Urticaria—Mitoxantrone—lymphatic system cancer	0.000607	0.00107	CcSEcCtD
Clonazepam—Hypersensitivity—Carmustine—lymphatic system cancer	0.000605	0.00107	CcSEcCtD
Clonazepam—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000604	0.00106	CcSEcCtD
Clonazepam—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000604	0.00106	CcSEcCtD
Clonazepam—Pneumonia—Methotrexate—lymphatic system cancer	0.0006	0.00106	CcSEcCtD
Clonazepam—Vomiting—Bleomycin—lymphatic system cancer	0.000598	0.00105	CcSEcCtD
Clonazepam—Drowsiness—Methotrexate—lymphatic system cancer	0.000597	0.00105	CcSEcCtD
Clonazepam—Depression—Methotrexate—lymphatic system cancer	0.000595	0.00105	CcSEcCtD
Clonazepam—Rash—Bleomycin—lymphatic system cancer	0.000593	0.00105	CcSEcCtD
Clonazepam—Dermatitis—Bleomycin—lymphatic system cancer	0.000593	0.00105	CcSEcCtD
Clonazepam—Asthenia—Carmustine—lymphatic system cancer	0.00059	0.00104	CcSEcCtD
Clonazepam—Hypersensitivity—Vincristine—lymphatic system cancer	0.000578	0.00102	CcSEcCtD
Clonazepam—Epistaxis—Methotrexate—lymphatic system cancer	0.000563	0.000992	CcSEcCtD
Clonazepam—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000563	0.000992	CcSEcCtD
Clonazepam—Asthenia—Vincristine—lymphatic system cancer	0.000563	0.000992	CcSEcCtD
Clonazepam—Diarrhoea—Carmustine—lymphatic system cancer	0.000562	0.000991	CcSEcCtD
Clonazepam—Nausea—Bleomycin—lymphatic system cancer	0.000559	0.000985	CcSEcCtD
Clonazepam—Asthenia—Mitoxantrone—lymphatic system cancer	0.000548	0.000966	CcSEcCtD
Clonazepam—Dizziness—Carmustine—lymphatic system cancer	0.000543	0.000958	CcSEcCtD
Clonazepam—Haemoglobin—Methotrexate—lymphatic system cancer	0.000538	0.000949	CcSEcCtD
Clonazepam—Diarrhoea—Vincristine—lymphatic system cancer	0.000537	0.000946	CcSEcCtD
Clonazepam—Haemorrhage—Methotrexate—lymphatic system cancer	0.000536	0.000944	CcSEcCtD
Clonazepam—Pharyngitis—Methotrexate—lymphatic system cancer	0.000532	0.000937	CcSEcCtD
Clonazepam—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000529	0.000932	CcSEcCtD
Clonazepam—Urethral disorder—Methotrexate—lymphatic system cancer	0.000525	0.000926	CcSEcCtD
Clonazepam—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000523	0.000921	CcSEcCtD
Clonazepam—Vomiting—Carmustine—lymphatic system cancer	0.000522	0.000921	CcSEcCtD
Clonazepam—Dizziness—Vincristine—lymphatic system cancer	0.000519	0.000914	CcSEcCtD
Clonazepam—Rash—Carmustine—lymphatic system cancer	0.000518	0.000913	CcSEcCtD
Clonazepam—Dermatitis—Carmustine—lymphatic system cancer	0.000518	0.000912	CcSEcCtD
Clonazepam—Visual impairment—Methotrexate—lymphatic system cancer	0.000516	0.00091	CcSEcCtD
Clonazepam—Headache—Carmustine—lymphatic system cancer	0.000515	0.000907	CcSEcCtD
Clonazepam—Eye disorder—Methotrexate—lymphatic system cancer	0.000501	0.000882	CcSEcCtD
Clonazepam—Vomiting—Vincristine—lymphatic system cancer	0.000499	0.000879	CcSEcCtD
Clonazepam—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000497	0.000876	CcSEcCtD
Clonazepam—Rash—Vincristine—lymphatic system cancer	0.000495	0.000872	CcSEcCtD
Clonazepam—Dermatitis—Vincristine—lymphatic system cancer	0.000494	0.000871	CcSEcCtD
Clonazepam—Headache—Vincristine—lymphatic system cancer	0.000491	0.000866	CcSEcCtD
Clonazepam—Nausea—Carmustine—lymphatic system cancer	0.000488	0.00086	CcSEcCtD
Clonazepam—Vomiting—Mitoxantrone—lymphatic system cancer	0.000486	0.000856	CcSEcCtD
Clonazepam—Immune system disorder—Methotrexate—lymphatic system cancer	0.000484	0.000853	CcSEcCtD
Clonazepam—Rash—Mitoxantrone—lymphatic system cancer	0.000482	0.000849	CcSEcCtD
Clonazepam—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000481	0.000848	CcSEcCtD
Clonazepam—Chills—Methotrexate—lymphatic system cancer	0.000481	0.000847	CcSEcCtD
Clonazepam—Headache—Mitoxantrone—lymphatic system cancer	0.000479	0.000843	CcSEcCtD
Clonazepam—Alopecia—Methotrexate—lymphatic system cancer	0.000473	0.000834	CcSEcCtD
Clonazepam—Mental disorder—Methotrexate—lymphatic system cancer	0.000469	0.000827	CcSEcCtD
Clonazepam—Malnutrition—Methotrexate—lymphatic system cancer	0.000466	0.000822	CcSEcCtD
Clonazepam—Nausea—Vincristine—lymphatic system cancer	0.000466	0.000821	CcSEcCtD
Clonazepam—Nausea—Mitoxantrone—lymphatic system cancer	0.000454	0.0008	CcSEcCtD
Clonazepam—Back pain—Methotrexate—lymphatic system cancer	0.000451	0.000795	CcSEcCtD
Clonazepam—Vision blurred—Methotrexate—lymphatic system cancer	0.000439	0.000775	CcSEcCtD
Clonazepam—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000433	0.000763	CcSEcCtD
Clonazepam—Anaemia—Methotrexate—lymphatic system cancer	0.000431	0.00076	CcSEcCtD
Clonazepam—Malaise—Methotrexate—lymphatic system cancer	0.000421	0.000741	CcSEcCtD
Clonazepam—Vertigo—Methotrexate—lymphatic system cancer	0.000419	0.000738	CcSEcCtD
Clonazepam—Leukopenia—Methotrexate—lymphatic system cancer	0.000417	0.000736	CcSEcCtD
Clonazepam—Cough—Methotrexate—lymphatic system cancer	0.000407	0.000717	CcSEcCtD
Clonazepam—Chest pain—Methotrexate—lymphatic system cancer	0.000397	0.0007	CcSEcCtD
Clonazepam—Myalgia—Methotrexate—lymphatic system cancer	0.000397	0.0007	CcSEcCtD
Clonazepam—Arthralgia—Methotrexate—lymphatic system cancer	0.000397	0.0007	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000394	0.000695	CcSEcCtD
Clonazepam—Discomfort—Methotrexate—lymphatic system cancer	0.000392	0.000691	CcSEcCtD
Clonazepam—Confusional state—Methotrexate—lymphatic system cancer	0.000384	0.000676	CcSEcCtD
Clonazepam—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000381	0.000671	CcSEcCtD
Clonazepam—Infection—Methotrexate—lymphatic system cancer	0.000378	0.000666	CcSEcCtD
Clonazepam—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000373	0.000658	CcSEcCtD
Clonazepam—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000373	0.000657	CcSEcCtD
Clonazepam—Skin disorder—Methotrexate—lymphatic system cancer	0.00037	0.000652	CcSEcCtD
Clonazepam—Anorexia—Methotrexate—lymphatic system cancer	0.000363	0.000639	CcSEcCtD
Clonazepam—Hypotension—Methotrexate—lymphatic system cancer	0.000356	0.000627	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000347	0.000611	CcSEcCtD
Clonazepam—Insomnia—Methotrexate—lymphatic system cancer	0.000344	0.000607	CcSEcCtD
Clonazepam—Dyspnoea—Methotrexate—lymphatic system cancer	0.000339	0.000598	CcSEcCtD
Clonazepam—Somnolence—Methotrexate—lymphatic system cancer	0.000338	0.000596	CcSEcCtD
Clonazepam—Dyspepsia—Methotrexate—lymphatic system cancer	0.000335	0.00059	CcSEcCtD
Clonazepam—Decreased appetite—Methotrexate—lymphatic system cancer	0.000331	0.000583	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000329	0.000579	CcSEcCtD
Clonazepam—Fatigue—Methotrexate—lymphatic system cancer	0.000328	0.000578	CcSEcCtD
Clonazepam—Pain—Methotrexate—lymphatic system cancer	0.000325	0.000574	CcSEcCtD
Clonazepam—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000314	0.000553	CcSEcCtD
Clonazepam—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000311	0.000549	CcSEcCtD
Clonazepam—Urticaria—Methotrexate—lymphatic system cancer	0.000302	0.000533	CcSEcCtD
Clonazepam—Body temperature increased—Methotrexate—lymphatic system cancer	0.000301	0.00053	CcSEcCtD
Clonazepam—Abdominal pain—Methotrexate—lymphatic system cancer	0.000301	0.00053	CcSEcCtD
Clonazepam—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00028	0.000494	CcSEcCtD
Clonazepam—Asthenia—Methotrexate—lymphatic system cancer	0.000273	0.000481	CcSEcCtD
Clonazepam—Pruritus—Methotrexate—lymphatic system cancer	0.000269	0.000475	CcSEcCtD
Clonazepam—Diarrhoea—Methotrexate—lymphatic system cancer	0.00026	0.000459	CcSEcCtD
Clonazepam—Dizziness—Methotrexate—lymphatic system cancer	0.000252	0.000444	CcSEcCtD
Clonazepam—Vomiting—Methotrexate—lymphatic system cancer	0.000242	0.000427	CcSEcCtD
Clonazepam—Rash—Methotrexate—lymphatic system cancer	0.00024	0.000423	CcSEcCtD
Clonazepam—Dermatitis—Methotrexate—lymphatic system cancer	0.00024	0.000423	CcSEcCtD
Clonazepam—Headache—Methotrexate—lymphatic system cancer	0.000238	0.00042	CcSEcCtD
Clonazepam—Nausea—Methotrexate—lymphatic system cancer	0.000226	0.000398	CcSEcCtD
